D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival

ConclusionThis study showed D2 lymphadenectomy for GA as an independent prognostic factor for OS, even after 5-y and until 10-y. Our study suggests that D2 should be offered as the curative-intent treatment for all patients with GA that fit to undergo surgery.SynopsisThis study addressed D2 lymphadenectomy for gastric adenocarcinoma as a prognostic factor of overall survival (OS) improving 3-y (51.1 versus 32.2%), 5-y (43.2 versus 26), and 10-yOS (30.6 versus 9.4%), p < 0.001. D2 lymphadenectomy should be offered for a curative-intent surgery.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research